CYCara E. Capitena Young

Cara E. Capitena Young

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cara E. Capitena Young has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical endoscopy as a diagnostic tool for atypical uveitis–glaucoma–hyphema syndrome

    by Maxwell S. Mayeda, Amit K. Reddy, Cara E. Capitena Young

    Introduction: Uveitis–glaucoma–hyphema (UGH) syndrome is a complication of cataract surgery due to iris chafing by a displaced intraocular lens (IOL). This case describes an inconspicuous presentation of UGH, in which diagnosis was aided by surgical endoscopic examination, a technique rarely described in the literature thus far. Patient and Clinical Findings: A 70-year-old woman presented with recurrent anterior uveitis, ocular hypertension, and iris abnormalities in the left eye. As her symptoms started after cataract extraction, there was concern for an IOL-induced uveitis. Results of slitlamp examination, gonioscopy, and ultrasound biomicroscopy (UBM) were indeterminant. Diagnosis, Intervention, and Outcomes: The patient elected for surgical endoscope evaluation of the inserted IOL, which revealed the superonasal haptic extending through a focal posterior capsular tear, with the terminal arm then resting on the anterior lens capsule against the posterior iris. The IOL was removed, and the patient was left aphakic. There has been no recurrence of uveitis now 26-month post-IOL removal. Conclusions: UGH is often difficult to diagnose, and obvious lens dislocation may not be seen with UBM or gonioscopy. Surgical endoscopy can be used in these cases to confirm the diagnosis.

  • Open Access

    Incidence of Corneal Graft Failure with Glaucoma Drainage Device Placement in the Anterior Chamber Compared to the Ciliary Sulcus

    by Emmeline J. Kim, Monica K. Ertel, Jennifer L. Patnaik, Maxwell Mayeda, Deidre St. Peter, Galia A. Deitz, Jeffrey R. SooHoo, Mina B. Pantcheva, Malik Y. Kahook, Leonard K. Seibold, et al.

    Introduction This study aimed to evaluate the rate of corneal graft failure in eyes with glaucoma drainage device (GDD) placed in the anterior chamber (AC) versus the ciliary sulcus (CS). Methods This was a retrospective chart review of eyes with coexisting corneal transplant and GDD between January 2014 and December 2021 at an academic medical center. The primary outcome was incidence of corneal transplant failure. Groups were compared with logistic regression modeling utilizing generalized estimating equations with an unstructured correlation to account for patients with two eyes included. Adjusted odds ratios (OR) and 95% confidence limits were determined for the primary outcome. Kaplan–Meier curves were used to demonstrate the time to failure. Results Among 58 eyes, the graft failure rate for GDDs placed in the AC versus CS was 42.5% and 10.5%, respectively (p = 0.05). Male patients had higher odds of failure, OR 3.5 (95% CI 1.1, 10.4, p = 0.03). Maximum intraocular pressure, topical carbonic anhydrase inhibitor use, and type of corneal graft were not significantly associated with failure. The Kaplan–Meier survival curve demonstrated higher corneal transplant failure probabilities for eyes with GDD in the AC versus CS (p = 0.06). GDD location, after adjusting for sex, was not significantly associated with failure, OR 3.0 (95% CI 0.8, 11.6, p = 0.10). Conclusions Corneal transplant failure rates were four times higher in eyes with GDDs in the AC compared to the CS, but the difference was not statistically significant. Further studies with larger sample sizes and follow-up are needed to fully explore differences in failure rates by GDD placement.

  • Open Access

    Kahook Dual Blade Goniotomy Outcomes in the Underserved Dominican Republic Black and Afro-Latinx Population

    by Cristos Ifantides, Hernan Bejar, Jennifer Patnaik, Erin Sieck, Mina Pantcheva, Cara Capitena Young, Margarita Arbaje, William McCollum

    Background/Objectives: Black and Afro-Latinx communities have a higher propensity for more-severe glaucoma at a younger age. This study aimed to use the Kahook Dual Blade (KDB) to treat all glaucoma subtypes and severity levels in this historically underserved community. Materials and Methods: This study involved a retrospective analysis of surgical case records, with follow-up through 20 months. The subjects were glaucoma patients at Hospital Elias Santana in Santo Domingo, Dominican Republic. Inclusion criteria were age >18 years and a minimum follow-up of 1 year after surgery. All glaucoma subtypes and disease severities were included, including previous glaucoma procedures. Sequential patients undergoing KDB goniotomy alone or in combination with phacoemulsification cataract surgery were assessed. IOP data and number of medications were collected at specific time points: baseline, postoperative day 1, postoperative week 1, and postoperative months 1, 3, 6, 12, 16, and 20. Surgical outcome was determined using IOP and number of medications. Success was defined as either a 20% or more reduction in IOP or a decrease in at least one topical therapy. Recorded postoperative complications were hyphema, ocular hypertension, and need for additional glaucoma surgery. Results: A total of 90 eyes from 90 patients were included. A total of 100% of the patient population was Black or Afro-Latinx. The most common glaucoma subtype was primary open-angle (76.7%). Most of the eyes had severe glaucoma (53.3%). The mean preoperative baseline IOP was 20.5 mmHg. The mean postoperative IOP from all time points ranged from 12.9 to 13.5 mmHg (all time points were significantly lower than baseline IOP, p < 0.0001). A mean reduction in IOP percent of at least 31.5% was seen at every time point. There was a mean reduction of two medications by postoperative month 20. Surgical success was achieved in 95.6% of patients at postoperative month 1 and remained high throughout the study period (95.4% at month 20). Conclusions: KDB goniotomy achieved successful IOP and medication reduction across all levels of glaucoma severity. Surgical success rates were maintained to 20 months. While MIGS has historically been used as an intervention in mild-to-moderate glaucoma, our study results show that the KDB can play a significant role in all stages of glaucoma, including severe. MIGS should be considered as a favorable intervention in all disease severities in Black and Afro-Latinx communities around the world.

  • Open Access

    Hydrus Microstent malposition with uveitis-glaucoma-hyphema syndrome

    by Cara E. Capitena Young, Deidre M. St Peter, Monica K. Ertel, Mina B. Pantcheva


  • Attitudes and Perceptions Toward Virtual Health in Eye Care During Coronavirus Disease 2019

    by Cara E. Capitena Young, Jennifer L Patnaik, Leonard K. Seibold, Malik Y. Kahook

    Purpose: To evaluate attitudes and perceptions toward virtual health (VH) and its usage among eye care providers before, during, and after the coronavirus disease 2019 (COVID-19) pandemic. Materials and Methods: In April and May 2020, an online survey comprised of questions regarding past and current VH practices, as well as plans for future use was distributed among eye care providers nationwide. Results: Of the 117 eye care providers who completed the survey, 96.6% were not using VH before the COVID-19 pandemic. In contrast, 77.4% reported using VH during the pandemic. The majority of visits were for red eye (64.4%, n = 56) and ocular surface complaints (58.6%, n = 51). Examination components tested virtually varied, but most respondents felt these were at least “somewhat reliable.” Almost half of respondents (45%) felt it was “very easy” or “somewhat easy” to implement VH and the majority (53.8%, n = 43) were able to get it up and running in under a week. The majority felt the transition to VH was positive (57.5%), however, only 50.4% ( n = 53) of those providers planned to use VH regularly once able to see patients safely in clinic again. Conclusions: While the majority of U.S. eye care providers who responded were not using VH before the COVID-19 pandemic, just months into the U.S. outbreak, 77.4% were using VH in their daily practice. In general, providers used these platforms for urgent examinations, adnexal disease, and postoperative care most often. The majority felt the transition was a positive one, however, only half planned to continue regular use of VH once the pandemic ended.


  • The Future Is Now: Incorporating Telemedicine into Glaucoma Care

    by Monica K. Ertel, Malik Y. Kahook, Cara E. Capitena Young

    Purpose of Review The field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice. Recent Findings Teleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction. Summary Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.


  • Daratumumab-induced Choroidal Effusion: A Case Report and Review of the Literature

    by Anne Strong, Michael Huvard, Jeffrey L. Olson, Tomer Mark, Cara Capitena Young